Please login to the form below

Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in a changing and challenging environment. Cello Health provides our clients with access to expertise, processes, IP and market knowledge spanning the pharmaceutical, biotechnology, diagnostics, healthcare equipment and consumer health sectors.

We offer our clients the best of both worlds: working with leading edge professionals who have extensive experience in their specialist field; and where appropriate a blended team spanning multiple capabilities:

Global marketing research and customer insight through Cello Health Insight
Strategic consultancy through Cello Health Consulting
Evidence and engagement through Cello Health Communications

By combining our extensive mix of capabilities, we will enable clients to look at complex market challenges through multiple lenses, to take critical decisions with greater confidence, and deliver commercial and clinical success in today’s healthcare landscape.   Cello Health offers a unique breadth and depth of experience, across everything from early stage product commercialisation, strategy and research, to how we communicate the evidence and understand the emerging impact of patient choice    

In addition to their pure health capabilities outlined above, The Value Engineers and RS Consulting, whilst both having healthcare clients, also offer brand strategy and research services across a wider range of industry sectors.

Areas of Expertise

Through its distinct capabilities, Cello Health is able to offer:

Global marketing research and customer insight through Cello Health Insight  www.cellohealthinsight.com
Strategic consultancy through Cello Health Consulting  www.cellohealthconsulting.com
Evidence and engagement through Cello Health Communications  www.cellohealthcommunications.com

Press Releases

Claire Derbyshire joins Cello Health Insight UK office
Strengthening the senior management team as newest client services director
Cello Health Communications Accelerates its Digital Offering with New Leadership Appointments
Rick Lang and Craig Lipski join the organization in senior digital roles
Duncan Munro joins Cello Health Insight as Joint Head of ‘IQ’ Practice
Supporting quantitative team’s continued growth, bringing specialist advanced analytics, methodological and technical expertise.
Maria Eletskaya joins Cello Health Insight
Bolstering senior team for expanding 'IQ' Quantitative practice
Cello Health appoints health economics and market access expert in the United States
Doctors Embracing Digital Technology – But Are Reluctant To Prescribe Apps And Wearables For Patients
Face-to-face communication still biggest influence on prescribing behaviour, says new report
Cello Health Launches ‘Fresh Thinking’ App To Deliver Tailored Thought Leadership Direct To Mobile Devices
Cello Health has launched a new smartphone and tablet app to enable pharma and healthcare industry professionals to receive thought leadership pieces, comments and insight on topics directly relevant to them as individuals.
Researchers Must Be ‘Digital Savvy’ – But Not View Technology As A Panacea, Says Newly-Promoted Digital Expert
Healthcare market researchers will increasingly need to be ‘digital savvy’ and familiar with the full array of digital methodologies, but these should be viewed as complementary to traditional methods, not as a low-cost replacement for them – that is the view of newly-promoted Digital Product Manager at Cello Health Insight, Peter Furness.
Cello Health BioConsulting Appoints Senior Pharma Marketer As President
Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of Jim Hall as President.
Experienced Healthcare Marketer Gareth Thurston, joins Cello Health Consulting
Specialist healthcare strategic marketing consultancy Cello Health Consulting has appointed experienced pharmaceutical marketing professional Gareth Thurston as a Consultant.
Cello Health BioConsulting adds another member to its senior team
Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of James McDermott as Vice-President.
NEW APPOINTMENTS AND PROMOTION SIGNAL EXPANSION OF CELLO HEALTH INSIGHT QUANTITATIVE RESEARCH TEAM
Healthcare market research agency Cello Health Insight has announced the appointment of a Senior Methodologist in its quantitative research ‘IQ’ team, reflecting growth in demand in this area across the firm’s range of healthcare and pharmaceutical clients.
TWO SENIOR APPOINTMENTS FOR CELLO HEALTH BIOCONSULTING
Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of Philip Vorhies and Mark Kasakevich as Vice-Presidents.
NEW SENIOR CONSULTANT FOR CELLO HEALTH CONSULTING
Specialist healthcare strategic marketing consultancy Cello Health Consulting has appointed senior marketing professional Robert Stringer as Senior Consultant.
CELLO HEALTH ANNOUNCES THE FORMATION OF CELLO HEALTH BIOCONSULTING IN THE US
Cello Health announces the formation of Cello Health BioConsulting in the US. Cello Health BioConsulting is a Strategic Management Consulting Firm focusing on Pharmaceuticals, Biotechnology and Medical Device companies in the United States. Cello Health BioConsulting will offer a unique set of services that focus on early product development, commercialization and business development support for small and mid-cap companies.
SENIOR PHARMA MARKETER JOINS CELLO HEALTH CONSULTING
Specialist healthcare strategic marketing consultancy Cello Health Consulting has appointed experienced pharma marketer Jon Gilbert as Senior Consultant.

White Papers and Resources

Managing value: Why early asset development and commercialization is important
Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development.
Optimising market research data in rare disease
Helping to provide powerful insights into the burden of disease and the patient-caregiver experience.
Strategy - It's All About Choices
If you are entirely comfortable about the decisions you have made about the future, then there is a very good chance that your strategy is not a good one.
Use digital to maximise the value of sales meetings
Doctors are becoming increasingly tech-savvy, but still want face-to-face interactions with reps. Think about how technology can be applied to enhance these meetings, rather than deploying tech for tech’s sake, urges Paul Mannu.
The Seven Cs Of Cross-Functional Brand Planning
As more and more organisations have moved to cross-functional and cross-regional involvement in the development of their strategic and operational brand plans, the result has been greater engagement and alignment, with richer outputs – but this approach comes with significant challenges. Jon Bircher distils his experience, learnings and observations about getting the most out of cross-functional teams in the process of brand planning into seven recommendations.
The Journey to excellence
Over the last 20 years much has changed in healthcare delivery. The autonomy of choice of healthcare practitioners has been constrained as individual healthcare systems come to terms with increasing patient expectations, the availability of more effective but also more expensive treatments, an increasing demand for healthcare from increasing and ageing populations plus finite resources to meet these demands. With those market, customer and competitive landscape changes have come increasing challenges for a marketing organisation such as multiple stakeholders, demands for more evidence of cost-effective outcome, smaller differentials between alternative treatment options to name but a few. Paul Stuart-Kregor looks at the changes in marketing over the last 20 years and discusses how responding effectively to customer need should be at the heart of what every marketer does - focussing on outcome/result not input/effort to ensure we are effective, as commercially we are not rewarded for effort but result.
Pragmatic Digital Health
At the beginning of 2015, we looked into our crystal ball and identified five areas where technology would have an impact on the world of healthcare: technology partnerships; compliance apps; artificial intelligence; the increased use of 3D printing; and finally, somewhat most ambitiously, the bionic person. Several months on, Paul Mannu looks at how those predictions have panned out.
Organisational Memory
In a knowledge-based industry with high labour mobility, retaining that knowledge within an organisation during a drug’s lifecycle can be tricky. If we undervalue the knowledge, experience and marketing understanding which is gathered over time within our organisations, then we risk seeing those valuable assets simply walk out of the door with each individual moving on to pastures new. Isaac Batley suggests five steps to improving that ‘organisational memory’.
Thoughts on the intersection between technology and psychology
Paul Mannu - Master Practitioner, Behavioural Insights at Cello Health Insight gives us his succinct thoughts on the intersection between technology and psychology
Learning to listen - Examining the opportunities and challenges of using conversations on social media for Pharma brands
The world in which we do business has markedly changed since 2008, which has helped to increase the push towards the ‘digitisation’ of marketing communications’ channels, This feature explores the merits of effective social media listening, but cautions that not all conversations are equal.
The changing face of primary care in the UK
The complexion of Britain’s primary care providers has changed beyond recognition in recent years. This is leading to significant consequences for the way pharma interacts with them, says Paul Mannu.
It's time to change the conversation
The world of drug promotion has changed. It has ceased to be a simple matter of detailing to physicians and an occasional pharmacist; it has evolved into a much more sophisticated activity, supported by new technology and much more targeted. However do we use these new technologies to do the same old things or do we use them instead to change our approach to promotional activities?
The future of oncology market research
Greater differentiation of diagnoses and treatments in cancer means market researchers are facing new challenges in dealing with very small numbers of patients sensitively while gaining the insights that pharma companies need to design appropriate tailored support. Jane Barrett explains how to balance these demands.
How to make the most of online communities
Jenny Fletcher explains some ways to gain the most from an online community, through treating participants as individuals and tailoring research methods to their preferences
Preparing for biopharma marketing in 2020 and beyond - Who is the marketer of the future?
Pharma operates in a constantly evolving landscape yet many companies persist with skills/competency surveys of their people and processes which define their capability level in terms of the last 12 months to today. This provides a healthy base-line, but does little to prepare for the future. ReadRussell Powter’s recently published feature published in the June issue of PM Europe to find out how can we help companies identify where they need to invest in order to prepare ahead and ensure their marketing teams are fit for purpose in the future.
Driving Innovation And Value Creation Through A Customer-Centric Culture
Pharma must seriously look at other sectors to learn how to deliver true customer centric thinking relevant to pharma, says Russell Powter.
MORE MONEY FOR THE NHS – BUT IS THIS THE ANSWER?
Paul Mannu of Cello Health Insight says that politicians opening their pre-election cheque books can’t put the NHS where it needs to be – but pharma can play a major role in doing so.
Antibiotic Resistance: Alarm bells ring louder than ever
Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be discovered and developed in this challenging field.

Latest Tweets

Company Details

Cello Health

+44 (0)20 7812 8460

Contact Website

Address:
11-13 Charterhouse Buildings
London
EC1M 7AP
UK

Latest content on this profile

Claire Derbyshire joins Cello Health Insight UK office
Strengthening the senior management team as newest client services director
Cello Health
Managing value: Why early asset development and commercialization is important
Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development.
Cello Health
Optimising market research data in rare disease
Helping to provide powerful insights into the burden of disease and the patient-caregiver experience.
Cello Health
Cello Health Communications Accelerates its Digital Offering with New Leadership Appointments
Rick Lang and Craig Lipski join the organization in senior digital roles
Cello Health
Duncan Munro joins Cello Health Insight as Joint Head of ‘IQ’ Practice
Supporting quantitative team’s continued growth, bringing specialist advanced analytics, methodological and technical expertise.
Cello Health
Maria Eletskaya joins Cello Health Insight
Bolstering senior team for expanding 'IQ' Quantitative practice
Cello Health